MyFinsight
Home
Blog
About
Depreciation of fixed assets
and amortization of...
$21,295K
(-56.08%↓ Y/Y)
Stock-based compensation
$14,958K
(-50.18%↓ Y/Y)
Accrued expenses
$11,868K
(180.87%↑ Y/Y)
Inventories, net
-$5,960K
(-126.06%↓ Y/Y)
Prepaid expenses and
other assets
-$4,915K
(-126.38%↓ Y/Y)
Sales of
available-for-sale investments
$17,000K
(-87.89%↓ Y/Y)
Net income (loss)
$4,653K
(13394.29%↑ Y/Y)
Deferred taxes
$3,914K
(82.13%↑ Y/Y)
Accounts payable
$3,184K
(-65.92%↓ Y/Y)
Changes in contingent
consideration
$1,663K
(154.85%↑ Y/Y)
Other liabilities
$1,071K
(-90.18%↓ Y/Y)
Amortization of cloud
computing arrangements
$663K
Amortization of debt issuance
costs and debt...
$577K
Net cash provided by
operating activities
$57,460K
(21.04%↑ Y/Y)
Net cash provided by
investing activities
$11,759K
(-67.81%↓ Y/Y)
Canceled cashflow
$17,261K
Canceled cashflow
$5,241K
Net increase in cash
and cash...
$61,569K
(159.68%↑ Y/Y)
Canceled cashflow
$7,650K
Accounts receivable, net
$10,507K
(904.49%↑ Y/Y)
Release of valuation
allowance on deferred tax...
$6,397K
Net accretion of
discount on...
$357K
Purchases of
available-for-sale investments
$3,905K
(-94.77%↓ Y/Y)
Purchases of fixed assets
$1,336K
(-88.12%↓ Y/Y)
Proceeds from shares
issued under employee...
$1,722K
(9.75%↑ Y/Y)
Proceeds from exercises
of stock options
$457K
Net cash used in
financing activities
-$7,650K
(87.36%↑ Y/Y)
Canceled cashflow
$2,179K
Repayment of revolving
credit facility
$5,000K
Payment of employee
withholding taxes on...
$3,493K
(-36.10%↓ Y/Y)
Excise taxes paid on
treasury stock...
$1,336K
Back
Back
Cash Flow
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)
source: myfinsight.com